GLENMARK — Glenmark Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹628.43bn
- IN₹620.37bn
- IN₹169.83bn
Brief: Glenmark Pharma Launches Vancomycin Hydrochloride For Injection USP, 500 Mg/Vial And 1 G/Vial
Brief: Glenmark Pharma Receives U.S. FDA Approval For Progesterone Vaginal Inserts, 100 Mg
Indian pharma shares extend losses on US tariffs; brokerages see limited impact
Indian pharma stocks fall on report of Trump's new tariffs on select drugmakers
Brief: Glenmark Pharma Gets Tax Demand And Penalty Of 160.5 Million Rupees Each
Brief: Glenmark Pharma To Directly Commercialize And Distribute Ryaltris In U.S. Effective
Chinese drugmaker Hengrui's quarterly profit misses forecasts amid generic drug business squeeze
Factbox: Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
Analysts upbeat on semaglutide opportunity as patent expiry triggers India generics
Brief: Glenmark Specialty SA Receives U.S. FDA Approval For Fluticasone Propionate Inhalation Aerosol Usp, 44 Mcg Per Actuation, With 180-Day Competitive Generic Therapy Exclusivity
Brief: Glenmark Pharma Says Glenmark Specialty SA Receives U.S. FDA Approval For Fluticasone Propionate Inhalation Aerosol USP
Brief: Glenmark Pharma To Launch Sodium Phosphates Injection In USA
Brief: Glenmark Pharma Posts Q3 Consol Net Profit 4.03 Billion Rupees
Brief: Glenmark Pharma Enters Exclusive Agreement With Hansoh Pharma
Brief: Glenmark Pharma USA To Launch Leucovorin Calcium For Injection USP, 350 Mg/Vial Single-Dose Vial
Brief: Cosmo And Glenmark Announce Market Authorisation Of Winlevi 10 Mg/G Cream
Brief: Glenmark Pharma Says US FDA Completes Inspection At Aurangabad Facility
Brief: Glenmark Pharma Receives EIR From US FDA For Monroe Facility
Brief: Glenmark Pharma Announces Launch Of Nebzmart, Gfb Smartules, Glenmark Airz, FB Smartules